These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2091065)

  • 1. Criteria for comparison of combined external radiotherapy and curietherapy.
    Sannazzari GL
    Rays; 1990; 15(4):539-45. PubMed ID: 2091065
    [No Abstract]   [Full Text] [Related]  

  • 2. Staging and target volume. Clinical problems in combined curietherapy and external radiotherapy.
    Volterrani F
    Rays; 1990; 15(4):476-80. PubMed ID: 2091058
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined external beam and interstitial radiotherapy. Radiobiological and clinical considerations.
    Biagini C
    Rays; 1990; 15(4):451-66. PubMed ID: 2091056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is "pulse dose rate" curietherapy comparable to low dose rate brachytherapy?].
    Lartigau E
    Bull Cancer Radiother; 1995; 82(3):336-9. PubMed ID: 8554885
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiobiological considerations of brachytherapy.
    Glicksman AS; Leith JT
    Oncology (Williston Park); 1988 Jan; 2(1):25-32. PubMed ID: 3079317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment volumes and dose specification in radiotherapy.
    Cellini N; Arcovito G; Piermattei A; Valentini V
    Rays; 1990; 15(4):467-75. PubMed ID: 2091057
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined curietherapy and teletherapy: radiobiology of time-dose relationship.
    Magno L
    Rays; 1990; 15(4):507-15. PubMed ID: 2091062
    [No Abstract]   [Full Text] [Related]  

  • 8. Innovations and advances in brachytherapy.
    Stitt JA; Thomadsen BR
    Semin Oncol; 1997 Dec; 24(6):696-706. PubMed ID: 9422265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
    Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
    Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The basic criteria of the Paris system.
    Loasses A
    Rays; 1990; 15(4):489-99. PubMed ID: 2091060
    [No Abstract]   [Full Text] [Related]  

  • 11. The Manchester system. Validity and principles.
    Bianchini G
    Rays; 1990; 15(4):481-8. PubMed ID: 2091059
    [No Abstract]   [Full Text] [Related]  

  • 12. Volume correction factor in time dose relationships in brachytherapy.
    Supe SJ; Sasane JB; Gupta MK
    Strahlenther Onkol; 1987 May; 163(5):309-13. PubMed ID: 3589957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients.
    Marijnen CA
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):706-10. PubMed ID: 17826039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for the treatment of primary vaginal cancer.
    Samant R; Tam T; Dahrouge S; E C
    Radiother Oncol; 2005 Nov; 77(2):133-6. PubMed ID: 16260055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.